Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and tolerability of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertension associated with In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil Palmitil Inhalation Powder (treprostinil palmitil)

Snippet

Sponsor: Insmed Incorporated | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED